Device Week, 28 August 2020 – Medtronic Goes After Competition; Freenome Attacks Colorectal Cancer
Executive Summary
This week’s podcast includes discussion of Medtronic’s latest sales and earnings report and an update on Freenome’s multiomics liquid biopsy test for early-stage colorectal cancer.
Listen to the podcast via the player below:
Medtech Insight articles addressing topics discussed in this episode: